MacFarland Suzanne P, Ebrahimzadeh Jessica E, Zelley Kristin, Begum Lubna, Bass Lee M, Brand Randall E, Dudley Beth, Fishman Douglas S, Ganzak Amanda, Karloski Eve, Latham Alicia, Llor Xavier, Plon Sharon, Riordan Mary K, Scollon Sarah R, Stadler Zsofia K, Syngal Sapna, Ukaegbu Chinedu, Weiss Jennifer M, Yurgelun Matthew B, Brodeur Garrett M, Mamula Petar, Katona Bryson W
Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Hospital of the University of Pennsylvania and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Cancer Prev Res (Phila). 2021 Feb;14(2):215-222. doi: 10.1158/1940-6207.CAPR-20-0348. Epub 2020 Oct 23.
Juvenile polyposis syndrome (JPS) is a clinically diagnosed hamartomatous polyposis syndrome that increases the risk of gastrointestinal cancer. Approximately 40%-50% of JPS is caused by a germline disease-causing variant (DCV) in the or genes. The aim of this study was to characterize the phenotype of DCV-negative JPS and compare it with DCV-positive JPS. Herein, we analyzed a cohort of 145 individuals with JPS from nine institutions, including both pediatric and adult centers. Data analyzed included age at diagnosis, family history, cancer history, need for colectomy/gastrectomy, and polyp number and location. Compared with DCV-positive JPS, DCV-negative JPS was associated with younger age at diagnosis ( < 0.001), lower likelihood of having a family history of JPS ( < 0.001), and a lower risk of colectomy ( = 0.032). None of the DCV-negative individuals had gastric or duodenal polyps, and polyp burden decreased after the first decade compared with DCV-positive JPS. Subgroup analysis between and carriers showed that carriers were more likely to have a family history of JPS and required gastrectomy. Taken together, these data provide the largest phenotypic characterization of individuals with DCV-negative JPS to date, showing that this group has distinct differences compared with JPS due to a or variant. Better understanding of phenotype and cancer risk associated with JPS both with and without a DCV may ultimately allow for individualized management of polyposis and cancer risk. Juvenile Polyposis Syndrome (JPS) is a gastrointestinal cancer predisposition syndrome requiring lifelong surveillance, however there is limited data comparing individuals with and without a germline disease-causing variant in or Herein we show that individuals with JPS without an underlying disease-causing variant have distinct phenotypic differences including lack of upper gastrointestinal polyps and lower rates of a family history of JPS, suggesting that a different approach to management may be appropriate in this population.
青少年息肉病综合征(JPS)是一种临床诊断的错构瘤性息肉病综合征,会增加患胃肠道癌的风险。约40%-50%的JPS由BMPR1A或SMAD4基因中的种系致病变异(DCV)引起。本研究的目的是描述DCV阴性JPS的表型,并将其与DCV阳性JPS进行比较。在此,我们分析了来自9个机构(包括儿科和成人中心)的145例JPS患者队列。分析的数据包括诊断年龄、家族史、癌症史、结肠切除术/胃切除术需求以及息肉数量和位置。与DCV阳性JPS相比,DCV阴性JPS与诊断时年龄较小(P<0.001)、有JPS家族史的可能性较低(P<0.001)以及结肠切除术风险较低(P=0.032)相关。DCV阴性个体均无胃或十二指肠息肉,与DCV阳性JPS相比,息肉负担在第一个十年后有所下降。BMPR1A和SMAD4携带者之间的亚组分析表明,BMPR1A携带者更有可能有JPS家族史且需要胃切除术。综上所述,这些数据提供了迄今为止DCV阴性JPS个体最大规模的表型特征,表明该组与由BMPR1A或SMAD4变异引起的JPS相比有明显差异。更好地了解与有或无DCV的JPS相关的表型和癌症风险最终可能有助于对息肉病和癌症风险进行个体化管理。青少年息肉病综合征(JPS)是一种需要终身监测的胃肠道癌易患综合征,然而,比较有或无BMPR1A或SMAD4种系致病变异的个体的数据有限。在此我们表明,没有潜在致病变异的JPS个体有明显的表型差异,包括缺乏上消化道息肉和JPS家族史发生率较低,这表明在该人群中可能适合采用不同的管理方法。